Department of Microbiology and Molecular Medicine, University Medical Center (CMU), University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.
Departments of Chemical Biology.
J Biol Chem. 2013 Sep 20;288(38):27002-27018. doi: 10.1074/jbc.M113.460709. Epub 2013 Aug 2.
In eukaryotic organisms, cysteine palmitoylation is an important reversible modification that impacts protein targeting, folding, stability, and interactions with partners. Evidence suggests that protein palmitoylation contributes to key biological processes in Apicomplexa with the recent palmitome of the malaria parasite Plasmodium falciparum reporting over 400 substrates that are modified with palmitate by a broad range of protein S-acyl transferases. Dynamic palmitoylation cycles require the action of an acyl-protein thioesterase (APT) that cleaves palmitate from substrates and conveys reversibility to this posttranslational modification. In this work, we identified candidates for APT activity in Toxoplasma gondii. Treatment of parasites with low micromolar concentrations of β-lactone- or triazole urea-based inhibitors that target human APT1 showed varied detrimental effects at multiple steps of the parasite lytic cycle. The use of an activity-based probe in combination with these inhibitors revealed the existence of several serine hydrolases that are targeted by APT1 inhibitors. The active serine hydrolase, TgASH1, identified as the homologue closest to human APT1 and APT2, was characterized further. Biochemical analysis of TgASH1 indicated that this enzyme cleaves substrates with a specificity similar to APTs, and homology modeling points toward an APT-like enzyme. TgASH1 is dispensable for parasite survival, which indicates that the severe effects observed with the β-lactone inhibitors are caused by the inhibition of non-TgASH1 targets. Other ASH candidates for APT activity were functionally characterized, and one of them was found to be resistant to gene disruption due to the potential essential nature of the protein.
在真核生物中,半胱氨酸棕榈酰化是一种重要的可逆修饰,影响蛋白质的靶向、折叠、稳定性和与伴侣的相互作用。有证据表明,蛋白质棕榈酰化有助于顶复门生物的关键生物学过程,最近疟原虫恶性疟原虫的棕榈酰组学报告称,有 400 多种蛋白质被广泛的蛋白质 S-酰基转移酶用棕榈酸修饰。动态棕榈酰化循环需要酰基蛋白硫酯酶 (APT) 的作用,该酶从底物中切割棕榈酸,并使这种翻译后修饰具有可逆性。在这项工作中,我们在刚地弓形虫中鉴定了 APT 活性的候选物。用低微摩尔浓度的β-内酯或三唑脲基抑制剂处理寄生虫,这些抑制剂针对人类 APT1,在寄生虫裂解周期的多个步骤中显示出不同的有害影响。使用活性探针结合这些抑制剂,揭示了几种丝氨酸水解酶的存在,这些水解酶被 APT1 抑制剂靶向。被鉴定为与人类 APT1 和 APT2 最接近的同源物的活性丝氨酸水解酶 TgASH1 进一步得到了表征。对 TgASH1 的生化分析表明,该酶对底物的特异性与 APTs 相似,同源建模指向 APT 样酶。TgASH1 对于寄生虫的生存是可有可无的,这表明β-内酯抑制剂观察到的严重影响是由非 TgASH1 靶点的抑制引起的。对其他可能具有 APT 活性的 ASH 候选物进行了功能表征,其中一种由于该蛋白可能具有必需性而对基因敲除具有抗性。